Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT03832673Phase 2Withdrawn
Pembrolizumab-Epacadostat Combination to Treat Muscle-invasive Bladder UrotheLIAl canceR: PECULIAR Study
Muscle-invasive Bladder Cancer
PrincipalinvestigatorStart date: 2019-05-22

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Fondazione IRCCS Istituto Nazionale Tumori-Milano

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Won Sik Ham

Department of Urology and Urological Science Institute, Yonsei University College of Medicine Seoul, Republic of Korea

Moderately Similar
1 trials

Shared therapeutic areas:

Muscle-invasive Bladder Cancer
Similarity Score30%

Julian Schardt, MD

Departement of Medical Oncology, University Hospital Berne

Moderately Similar
1 trials

Shared therapeutic areas:

Muscle-invasive Bladder Cancer
Similarity Score30%

xiongjun YE

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Moderately Similar
2 trials

Shared therapeutic areas:

Muscle-invasive Bladder Cancer
Similarity Score30%

Srikala Sridhar, MD

Princess Margaret Hospital, Canada

Moderately Similar
1 trials

Shared therapeutic areas:

Muscle-invasive Bladder Cancer
Similarity Score30%

Zhuowei Liu, M.D Ph.D

Sun Yat-Sen University Cancer Center

Moderately Similar
1 trials

Shared therapeutic areas:

Muscle-invasive Bladder Cancer
Similarity Score30%

Ur Metser, MD

Princess Margaret Hospital, Canada

Moderately Similar
2 trials

Shared therapeutic areas:

Muscle-invasive Bladder Cancer
Similarity Score30%

Jianzhong Shou

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Moderately Similar
1 trials

Shared therapeutic areas:

Muscle-invasive Bladder Cancer
Similarity Score30%

Zejing Wang, MD/PhD

Pfizer

Moderately Similar
1 trials

Shared therapeutic areas:

Muscle-invasive Bladder Cancer
Similarity Score30%

Nicholas Power, MD

LHSC-Victoria Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Muscle-invasive Bladder Cancer
Similarity Score30%

Fernando Maluf, MD

Hospital Israelita Albert Einstein

Moderately Similar
2 trials

Shared therapeutic areas:

Muscle-invasive Bladder Cancer
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT03832673Phase 2PrincipalInvestigator

Pembrolizumab-Epacadostat Combination to Treat Muscle-invasive Bladder UrotheLIAl canceR: PECULIAR Study

Muscle-invasive Bladder Cancer
Withdrawn

All 1 trials loaded